GL1X · GenesisL1 explorer

UniProt P27986

Phosphatidylinositol 3-kinase regulatory subunit alpha (P27986)

Phosphatidylinositol 3-kinase regulatory subunit alpha (UniProt P27986): 135 experimental structures on GenesisL1, 12 ligands bound, 226 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P27986
Protein
Phosphatidylinositol 3-kinase regulatory subunit alpha
Experimental structures
135
Predicted models
0
Ligands
12
Pockets
226 · 30 records with a druggable one

Structures

135 records of P27986 in the MolNFT archive: 135 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1A0NNMR study of the SH3 domain from fyn proto-oncogene tyrosine kinase complexed with the synthetic…solution nmrA——
1A0NNMR study of the SH3 domain from fyn proto-oncogene tyrosine kinase complexed with the synthetic…solution nmrA——
1AZGNMR study of the SH3 domain from fyn proto-oncogene tyrosine kinase kinase complexed with the…solution nmrA——
1AZGNMR study of the SH3 domain from fyn proto-oncogene tyrosine kinase kinase complexed with the…solution nmrA——
1H9OPhosphatidylinositol 3-kinase, P85-alpha subunit: C-terminal SH2 domain complexed with a TYR751…x-ray diffractionA——
1H9OPhosphatidylinositol 3-kinase, P85-alpha subunit: C-terminal SH2 domain complexed with a TYR751…x-ray diffractionA——
1PBWStructure of BCR-homology (bh) domainx-ray diffractionA, B——
1PBWStructure of BCR-homology (bh) domainx-ray diffractionA, B——
1PHTPhosphatidylinositol 3-kinase P85-alpha subunit SH3 domain, residues 1-85x-ray diffractionA——
1PHTPhosphatidylinositol 3-kinase P85-alpha subunit SH3 domain, residues 1-85x-ray diffractionA——
1PICPhosphatidylinositol 3-kinase, P85-alpha subunit: C-terminal SH2 domain complexed with a TYR751…solution nmrA——
1PICPhosphatidylinositol 3-kinase, P85-alpha subunit: C-terminal SH2 domain complexed with a TYR751…solution nmrA——
1PKSStructure of the PI3K SH3 domain and analysis of the SH3 familysolution nmrA——
1PKSStructure of the PI3K SH3 domain and analysis of the SH3 familysolution nmrA——
1PKTStructure of the PI3K SH3 domain and analysis of the SH3 familysolution nmrA——
1PKTStructure of the PI3K SH3 domain and analysis of the SH3 familysolution nmrA——
2IUGCrystal structure of the PI3-kinase p85 N-terminal SH2 domainx-ray diffractionA——
2IUGCrystal structure of the PI3-kinase P85 N-terminal SH2 domainx-ray diffractionA——
2IUHCrystal structure of the PI3-kinase p85 N-terminal SH2 domain in complex with c-Kit phosphotyrosyl…x-ray diffractionA——
2IUHCrystal structure of the PI3-kinase P85 N-terminal SH2 domain in complex with C-kit phosphotyrosyl…x-ray diffractionA——
2IUICrystal structure of the PI3-kinase p85 N-terminal SH2 domain in complex with PDGFR phosphotyrosyl…x-ray diffractionA, B——
2IUICrystal structure of the PI3-kinase P85 N-terminal SH2 domain in complex with pdgfr phosphotyrosyl…x-ray diffractionA, B——
2RD0Structure of a human p110alpha/p85alpha complexx-ray diffractionB——
2RD0Structure of a human P110ALPHA/P85ALPHA complexx-ray diffractionB——
2V1YStructure of a phosphoinositide 3-kinase alpha adaptor-binding domain (ABD) in a complex with the…x-ray diffractionB——
2V1YStructure of a phosphoinositide 3-kinase alpha adaptor- binding domain (abd) in a complex with the…x-ray diffractionB——
3HHMCrystal structure of p110alpha H1047R mutant in complex with niSH2 of p85alpha and the drug…x-ray diffractionB——
3HHMCrystal structure of P110ALPHA H1047R mutant in complex with NISH2 of P85ALPHA and the drug…x-ray diffractionB——
3HIZCrystal structure of p110alpha H1047R mutant in complex with niSH2 of p85alphax-ray diffractionB——
3HIZCrystal structure of P110ALPHA H1047R mutant in complex with NISH2 of P85ALPHAx-ray diffractionB——
3I5RPI3K SH3 domain in complex with a peptide ligandx-ray diffractionA——
3I5RPI3K SH3 domain in complex with a peptide ligandx-ray diffractionA——
3I5SCrystal structure of PI3K SH3x-ray diffractionA, B, C, D——
3I5SCrystal structure of PI3K SH3x-ray diffractionA, B, C, D——
4A55Crystal structure of p110alpha in complex with iSH2 of p85alpha and the inhibitor PIK-108x-ray diffractionB——
4A55Crystal structure of P110ALPHA in complex with ISH2 of P85ALPHA and the inhibitor pik-108x-ray diffractionB——
4JPSCo-crystal Structures of the Lipid Kinase PI3K alpha with Pan and Isoform Selective Inhibitorsx-ray diffractionB——
4JPSCo-crystal structures of the lipid kinase PI3K alpha with pan and isoform selective inhibitorsx-ray diffractionB——
4L1BCrystal Structure of p110alpha complexed with niSH2 of p85alphax-ray diffractionB——
4L1BCrystal structure of P110ALPHA complexed with NISH2 of P85ALPHAx-ray diffractionB——
4L23Crystal Structure of p110alpha complexed with niSH2 of p85alpha and PI-103x-ray diffractionB——
4L23Crystal structure of P110ALPHA complexed with NISH2 of P85ALPHA and pi-103x-ray diffractionB——
4L2YCrystal Structure of p110alpha complexed with niSH2 of p85alpha and compound 9dx-ray diffractionB——
4L2YCrystal structure of P110ALPHA complexed with NISH2 of P85ALPHA and compound 9Dx-ray diffractionB——
4OVUCrystal Structure of p110alpha in complex with niSH2 of p85alphax-ray diffractionB——
4OVUCrystal structure of P110ALPHA in complex with NISH2 of P85ALPHAx-ray diffractionB——
4OVVCrystal Structure of PI3Kalpha in complex with diC4-PIP2x-ray diffractionB——
4OVVCrystal structure of PI3KALPHA in complex with DIC4-PIP2x-ray diffractionB——
4WAFCrystal Structure of a novel tetrahydropyrazolo[1,5-a]pyrazine in an engineered PI3K alphax-ray diffractionB——
4WAFCrystal structure of a novel TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE in an engineered PI3K alphax-ray diffractionB——
4YKNPi3K alpha lipid kinase with Active Site Inhibitorx-ray diffractionA——
4YKNPI3K alpha lipid kinase with active site inhibitorx-ray diffractionA——
4ZOPCo-crystal structure of lipid kinase PI3K alpha with a selective phosphatidylinositol-3 kinase…x-ray diffractionB——
5AULPI3K p85 C-terminal SH2 domain/CD28-derived peptide complexx-ray diffractionA——
5AULPI3K P85 C-terminal SH2 DOMAIN/CD28-derived peptide complexx-ray diffractionA——
5FI4Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse…x-ray diffractionB——
5FI4Discovery of IMIDAZO[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse…x-ray diffractionB——
5GJIPI3K P85 N-terminal SH2 DOMAIN/CD28-derived peptide complexx-ray diffractionA——
5ITDCrystal structure of PI3K alpha with PI3K delta inhibitorx-ray diffractionB——
5ITDCrystal structure of PI3K alpha with PI3K delta inhibitorx-ray diffractionB——

75 records more on the page itself.

Ligands

  • SO4 · Sulfate ion · in 5 records
  • 70V · 2-methylcyclohexane-1,3-dione · in 2 records
  • 71F · 2-methoxybenzoic acid · in 2 records
  • 71J · trans-cyclohexane-1,4-diol · in 2 records
  • CAQ · Catechol · in 2 records
  • ES3 · 4-bromo-1H-imidazole · in 2 records
  • SOA · Isatoic anhydride · in 2 records
  • 2ZV · 4-methyl-3-nitropyridin-2-amine · in 1 record
  • 71G · 3-aminobenzonitrile · in 1 record
  • 71K · 2-methylbenzene-1,3-diamine · in 1 record
  • 71M · 6-methylpyridin-2-amine · in 1 record
  • SAL · 2-hydroxybenzoic acid · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.